For early stages
For superficial cancer
which does not invade the muscular layer of the bladder
, BCG administered in the bladder is superior to chemotherapy drugs administered in a similar fashion.
Bcg reduces the risk of recurrence, but may only delay progression in the long term. Bcg is not appropriate for muscle invasive disease, but some chemotherapy drugs given IV are very effective against such cancers.